SEC Company Response from Twist Bioscience Corp (TWST) (CIK 0001581280) (TWST) — Oct 26, 2018
Twist Bioscience Corp (TWST) (CIK 0001581280)
Date: Oct. 26, 2018 · CIK: 0001581280 · Accession: 0001193125-18-309372
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227672
Letter
455 Mission Bay Blvd South
Suite 545
San Francisco, CA 94158
October 26, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Amanda Ravitz
Geoffrey Kruczek
Re: Twist Bioscience Corporation Acceleration Request
Acceleration Request
Requested Date: October 30, 2018
Requested Time: 5:00 p.m. Eastern Time
Ladies and Gentlemen:
Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-227672), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Peter M. Lamb or Andrew D. Thorpe, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Lamb at (650) 289-7117, or in his absence, Mr. Thorpe at (415) 773-5970.
[Signature page follows]
Sincerely,
TWIST BIOSCIENCE CORPORATION
Show Raw Text
CORRESP 1 filename1.htm CORRESP 455 Mission Bay Blvd South Suite 545 San Francisco, CA 94158 October 26, 2018 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Amanda Ravitz Geoffrey Kruczek Re: Twist Bioscience Corporation Acceleration Request Acceleration Request Requested Date: October 30, 2018 Requested Time: 5:00 p.m. Eastern Time Ladies and Gentlemen: Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-227672), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Peter M. Lamb or Andrew D. Thorpe, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Mr. Lamb at (650) 289-7117, or in his absence, Mr. Thorpe at (415) 773-5970. [Signature page follows] Sincerely, TWIST BIOSCIENCE CORPORATION By: /s/ Mark Daniels Name: Mark Daniels Title: General Counsel, Secretary and Chief Ethics and Compliance Officer cc: Emily Leproust, Twist Bioscience Corporation Andrew D. Thorpe, Orrick, Herrington & Sutcliffe, LLP Peter M. Lamb, Orrick, Herrington & Sutcliffe, LLP Brian J. Cuneo, Latham & Watkins LLP